In AD, it has been shown that Aβ and tau result in a hyper-activated M1 phenotype of microglial cells, leading to detrimental brain damage concomitant with the expression of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6. Here, MAPT is linked to Alzheimer disease.